Lichen International Ltd(LICN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 5:55 PM ET (Korea 10/31 06:55)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -1.48 | Insider Own | 0.68% | Shs Outstand | 16.2M | Perf Week | -44.78% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 16.2M | Perf Month | -44.78% |
| Enterprise Value | -0.01B | PEG | - | EPS next Q | - | Inst Own | 1.02% | Short Float | 0.87% | Perf Quarter | -51.8% |
| Income | -0.02B | P/S | 0.45 | EPS this Y | - | Inst Trans | 1.76% | Short Ratio | 4.54 | Perf Half Y | -87.63% |
| Sales | 0.02B | P/B | 0.15 | EPS next 5Y | - | ROA | -36.46% | Short Interest | 0.14M | Perf YTD | -79.83% |
| Book/sh | 3.73 | P/C | 0.47 | EPS past 3/5Y | - | ROE | -38.61% | 52W High | -94.01% ($9.49) | Perf Year | -85.75% |
| Cash/sh | 1.2 | P/FCF | - | Sales past 3/5Y | -10.15% -4.38% | ROIC | -39.56% | 52W Low | -19.32% ($0.70) | Perf 3Y | -99.78% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 96.86% | Gross Margin | 10.73% | Volatility(W/M) | 12.96% 12.15% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | -0.49 | Sales Y/Y TTM | -45.48% | Oper. Margin | -87.13% | ATR (14) | 0.1 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.81 | EPS Q/Q | 97.86% | Profit Margin | -117.7% | RSI (14) | 26.58 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.81 | Sales Q/Q | -28.02% | SMA20 | -36.85% ($0.9) | Beta | -1 | Target Price | - |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | -44.45% ($1.03) | Rel Volume | 2.64 | Prev Close | $0.75 |
| Employees | 410 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -77.24% ($2.5) | Avg Volume(3M) | 0.03M | Price | $0.57 |
| IPO | 2023/2/6 | Option/Short | No/Yes | Trades | 562 | Volume | 81,832 | Change | -24.16% |
The company is a professional services firm leading the next generation of management consulting across China, providing financial and tax solutions integrated with AI technology. It is pursuing aggressive expansion into the Asian market through the recent establishment of a Singapore subsidiary and a global brand renewal.
Over the past 1 year, on the lower side
94% below its 1-year high.
Traded more than usual. That is 264% of its average volume.
LICN has a sound balance sheet but weak earning power
Of every $100 in sales, $87.13 is lost.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $45. Peers typically go for $122.
Tap to view numbers
Holding long would have lost money
Bought 3 years ago, your return today would be -99.8%.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 1.0%.
Tap to view numbers
It ranks #39 of 44 in the industry
Based on market cap of $9M.
PMEC#38 Primech Holdings Ltd $13M PER - LICN#39 Lichen International Ltd $9M PER - 
SFHG#40 Samfine Creation Holdings Group Ltd $8M PER - 
THH#41 TryHard Holdings Ltd $7M PER - 
CRE#42 Cre8 Enterprise Ltd $5M PER 6.6 
FAQ
What kind of company is LICN?
LICN belongs to the Industrials sector and operates in the Specialty Business Services industry.
What is the market cap of LICN?
The market cap of LICN is approximately $9M, ranking 5,454 within its sector.
What is the 52-week high and low for LICN?
LICN has recorded a 52-week high of $9.49 and a low of $0.70.
